These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31760596)

  • 21. Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy.
    van Grinsven EE; Cialdella F; Verhoeff JJC; Philippens MEP; van Zandvoort MJE
    Psychooncology; 2023 Nov; 32(11):1752-1761. PubMed ID: 37789598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective analysis of neuropsychological deficits following resection of benign skull base meningiomas.
    Zweckberger K; Hallek E; Vogt L; Giese H; Schick U; Unterberg AW
    J Neurosurg; 2017 Dec; 127(6):1242-1248. PubMed ID: 28186454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
    Meyers CA; Smith JA; Bezjak A; Mehta MP; Liebmann J; Illidge T; Kunkler I; Caudrelier JM; Eisenberg PD; Meerwaldt J; Siemers R; Carrie C; Gaspar LE; Curran W; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2004 Jan; 22(1):157-65. PubMed ID: 14701778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.
    Habets EJ; Dirven L; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Taphoorn MJ
    Neuro Oncol; 2016 Mar; 18(3):435-44. PubMed ID: 26385615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
    Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
    Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.
    Salans M; Tibbs MD; Huynh-Le MP; Yip A; Tringale K; Karunamuni R; Xu R; Reyes A; Macari AC; Pan-Weisz T; McDonald CR; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):754-763. PubMed ID: 34102297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of 4-month neurocognitive function as an endpoint in brain metastases trials.
    Onodera S; Aoyama H; Tha KK; Hashimoto N; Toyomaki A; Terae S; Shirato H
    J Neurooncol; 2014 Nov; 120(2):311-9. PubMed ID: 25037611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
    Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK;
    J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
    Lawrie TA; Gillespie D; Dowswell T; Evans J; Erridge S; Vale L; Kernohan A; Grant R
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013047. PubMed ID: 31425631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between tumor location and neurocognitive functioning using tumor localization maps.
    Habets EJJ; Hendriks EJ; Taphoorn MJB; Douw L; Zwinderman AH; Vandertop WP; Barkhof F; De Witt Hamer PC; Klein M
    J Neurooncol; 2019 Sep; 144(3):573-582. PubMed ID: 31410731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive function in head and neck cancer patients prior to treatment.
    Bond SM; Dietrich MS; Murphy BA
    Support Care Cancer; 2012 Jan; 20(1):149-57. PubMed ID: 21229270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal-sparing radiotherapy and neurocognitive impairment: A systematic literature review.
    Giuseppe ZR; Silvia C; Eleonora F; Gabriella M; Marica F; Silvia C; Mario B; Francesco D; Savino C; Milly B; Frezza GP; Maurizio Z; Morganti AG
    J Cancer Res Ther; 2020; 16(6):1215-1222. PubMed ID: 33342776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive and psychological functioning of pediatric brain tumor patients undergoing proton beam therapy for three different tumor types.
    Youn SH; Ha B; Lee EH; Park B; Yang SE; Yu ES; Kim JY
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29430. PubMed ID: 34766721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
    Gondi V; Hermann BP; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e487-93. PubMed ID: 22209148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
    Kahalley LS; Douglas Ris M; Mahajan A; Fatih Okcu M; Chintagumpala M; Paulino AC; Whitehead WE; Minard CG; Stancel HH; Orobio J; Xue JJ; Warren EA; Grosshans DR
    Neuro Oncol; 2019 Jun; 21(6):809-818. PubMed ID: 30753584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy.
    Fournier-Goodnight AS; Ashford JM; Merchant TE; Boop FA; Indelicato DJ; Wang L; Zhang H; Conklin HM
    J Neurooncol; 2017 Aug; 134(1):97-105. PubMed ID: 28540667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors.
    Torres IJ; Mundt AJ; Sweeney PJ; Llanes-Macy S; Dunaway L; Castillo M; Macdonald RL
    Neurology; 2003 Apr; 60(7):1113-8. PubMed ID: 12682316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.